A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated Interferon alpha 2-alpha (PegIFN)Sponsor:   AbbVieActive, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials